The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression

A Kautzky, P Baldinger, D Souery… - European …, 2015 - Elsevier
For over a decade, the European Group for the Study of Resistant Depression (GSRD) has
examined single nucleotide polymorphisms (SNP) and clinical parameters in regard to …

Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.

D Souery, P Oswald, I Massat… - Journal of Clinical …, 2007 - legacy.psychiatrist.com
Objectives: Very few studies have investigated clinical features associated with treatment-
resistant depression (TRD) defined as failure of at least 2 consecutive antidepressant trials …

What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials

MT Berlim, G Turecki - European Neuropsychopharmacology, 2007 - Elsevier
OBJECTIVE: To summarize and discuss the conceptual and operational definitions of
treatment resistant/refractory depression (TRD) by systematically reviewing randomized …

Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples

C Fabbri, S Kasper, A Kautzky, L Bartova… - The British Journal of …, 2019 - cambridge.org
BackgroundTreatment-resistant depression (TRD) is the most problematic outcome of
depression in terms of functional impairment, suicidal thoughts and decline in physical …

The hidden third: improving outcome in treatment-resistant depression

TE Schlaepfer, H Ågren, P Monteleone… - Journal of …, 2012 - journals.sagepub.com
Treatment-resistant depression (TRD) presents many challenges for both patients and
physicians. This review aims to evaluate the current status of the field of TRD and reflects the …

Definition, assessment, and staging of treatment—resistant refractory major depression: a review of current concepts and methods

MT Berlim, G Turecki - The Canadian Journal of Psychiatry, 2007 - journals.sagepub.com
Objective: Up to 15% of depression patients eventually present with treatment-resistant or
refractory depression (TRD), a condition that causes significant social and economic …

[HTML][HTML] Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological …

D Bennabi, T Charpeaud, A Yrondi, JB Genty… - BMC psychiatry, 2019 - Springer
Background Clear guidance for successive antidepressant pharmacological treatments for
non-responders in major depression is not well established. Method Based on the …

A review of the conceptualisation and risk factors associated with treatment‐resistant depression

JA Murphy, J Sarris, GJ Byrne - Depression research and …, 2017 - Wiley Online Library
Major depression does not always remit. Difficult‐to‐treat depression is thought to contribute
to the large disease burden posed by depression. Treatment‐resistant depression (TRD) is …

Empirical testing of two models for staging antidepressant treatment resistance

T Petersen, GI Papakostas, MA Posternak… - Journal of clinical …, 2005 - journals.lww.com
Background: An increasing amount of attention has been paid to treatment resistant
depression. Although it is quite common to observe nonremission to not just one but …

A clinical risk stratification tool for predicting treatment resistance in major depressive disorder

RH Perlis - Biological psychiatry, 2013 - Elsevier
BACKGROUND: Early identification of depressed individuals at high risk for treatment
resistance could be helpful in selecting optimal setting and intensity of care. At present …